×
  • My Account
  • About
  • Omnipresent
  • Events
  • Work for us
  • Contact
  • Team Members

Browse

  • Journals
  • Media
  • Careers
  • Gold
  • Education
  • Covid-19
  • Journals
  • Media
  • Careers
  • Gold
  • Education
  • Covid-19
  • More
  • Login / Register
  • Journals
  • Media
  • Careers
  • Gold
  • Education
  • Covid-19
  • Login / Register

Login to continue

Members

Forgotten your password?

Create Account

Create your own personal healthcare feed, full of the latest content from across our divisions.

Register

You must accept all conditions before being able to view the post
Continue
Logo
Personalise Content

Omnipresent

Filter By Therapeutic Area

Cardiology
Reproductive Health
Oncology
Innovations
Respiratory
Allergy & Immunology
Gastroenterology
Urology
Neurology
Diabetes
Nephrology
Dermatology
Hematology
Hepatology
Interventional Cardiology
Rheumatology
Other
Pharma
Microbiology & Infectious Diseases
Radiology

Filter By Content Type

Webinars
Blog
Interviews
News
Press Release
Video

Overactive Bladder: Evaluation and Management

04 Feb 2021
Urology

Overactive Bladder: Terminology, Controversies and Pathophysiology

29 Jan 2021
Urology

Gene Signature Predicts Prostate Cancer Metastasis Risk

04 Dec 2020
Urology

Smart Device Designed for Underactive Bladders

04 Dec 2020
Urology

Q&A Webinar on the Management of Recurrent Cystitis

29 Oct 2020
Urology

Higher Central Adiposity linked to Increased Risk of Prostate Cancer Death

04 Sep 2020
Urology

Do COVID-19 Related Prostate Cancer Treatment Delays Impact Oncological Outcomes?

04 Sep 2020
Urology

Master Class in Bladder Cancer: Practical Solutions to Common Scenarios in NMIBC

24 Aug 2020
Urology

Liquid Biopsies of Over 1,000 Blood Samples from Men with Prostate Cancer Indicates Mens’ Response to Treatment

08 Jun 2020
Urology

Could Sugars Provide Accurate Testing for Prostate Cancer Diagnosis?

08 Jun 2020
Urology

Combined MRI Method as Superior Diagnostic Tool in Prostate Cancer

11 Mar 2020
Urology

Large Trial Explores Antioxidant Treatment in Male Infertility

11 Mar 2020
Urology

Prostate Cancer Risk Lowered by Active Lifestyle

16 Dec 2019
Urology

Anthrax Combined with Growth Factor Kills Bladder Cancer Cells

16 Dec 2019
Urology

Blood Test Could Replace Invasive Biopsies in Prostate Cancer Detection

24 Sep 2019
Urology

Prostate Cancer Risk Linked to Increased Levels of Progenitor Cells

24 Sep 2019
Urology

PD-1/PD-L1-Related Adverse Events Linked to Urothelial Carcinoma Outcomes

25 Jun 2019
Urology

Combined Systematic and Targeted Biopsy Optimally Detects Prostate Cancer

25 Jun 2019
Urology

EAU 2019 – Congress Highlights

23 Apr 2019
Urology

EAU 2019 – Opening Ceremony

18 Apr 2019
Urology

EAU 2019 – Interview – Prof Hendrik Van Poppel

16 Apr 2019
Urology

New Insights into Prostate Cancer Treatment

26 Mar 2019
Urology

A New Tool for Kidney Stone Prediction

26 Mar 2019
Urology

Advancements and Trends in Urology

19 Dec 2018
Urology

Pelvic Floor Exercises and Overactive Bladder

17 Dec 2018
Urology

New Genes Linked to Prostate Cancer

17 Dec 2018
Urology

Hyponatraemia Patients May Benefit from Treatment with Oral Urea

25 Sep 2018
Urology

Hormone Therapy for Prostate Cancer May Increase the Risk of Liver Disease

25 Sep 2018
Urology
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • →
  • About us
  • Work for us
  • Omnipresent
  • Register
  • My Account
  • Contact
Copyright © 2021 European Medical Group LTD. All rights reserved. European Medical Group is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendation.

Ts & Cs | Privacy Policy

Website by vercossa
UKAS ISO 9001

Proud to be ISO9001 Certified.

The ISO 9001 standard is an internationally recognised standard that is based on a number of quality management principles including a strong customer focus, the management of process change, effective methods of reducing non- compliance, and the continual improvement in the quality of our services.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.

Accept